The rising popularity in GLP-1 agonists for diabetes has sparked a debate about application forms : patches versus tablets . Traditionally , GLP-1 therapies were solely available in oral form, but the https://anniejlyk696113.blog2freedom.com/41070558/glp-1-transdermal-delivery-systems-vs-oral-medications-what-right-for-the-patient